Located in Saint-Hyacinthe, City of biotechnology, one of the most important economic poles of Quebec and Eastern Canada, Sterinova has an establishment license issued by Health Canada, on January 2016, for the manufacturing of sterile biologics.

Products made in Saint-Hyacinthe are manufactured with the latest technological equipment and the whole production process meets the Canadian Good Manufacturing Practices (cGMP) and they have an objective to meets the European and American requirements.

Sterinova is one of the few pharmaceutical companies in the world to be entirely dedicated to the manufacture of ready-to-use injectables. Its syringe production capacity is measured in tens of millions of unit per year and its production capacity for intravenous solution bags is close to a million units per year.